USE OF OMEPRAZOL: DESCRIPTIVE STUDY OF ELDERLY PATIENTS FROM A FAMILY HEALTH UNIT (FHU) OF RIBEIRÃO PRETO, SP, BRASIL

Authors

  • Jean Mozart de Lima Universidade de São Paulo. Faculdade de Medicina de Ribeirão Preto. Programa de Residência Multiprofissional em atenção integral a saúde. Av. Bandeirantes, 3900 - Monte Alegre - CEP: 14049-900 Ribeirão Preto/SP.
  • Amaury Lelis Dal Fabbro Universidade de São Paulo. Faculdade de Medicina de Ribeirão Preto. Departamento de Medicina Social. Av. Bandeirantes, 3900 - Monte Alegre - CEP: 14049-900 Ribeirão Preto/SP.
  • André Rodrigues Funayama Fundação de Apoio Ao Ensino, Pesquisa e Assistência do HCFMRP-USP. Av. Bandeirantes, 3900 - Vila Monte Alegre, Ribeirão Preto - SP, 14048-900

DOI:

https://doi.org/10.14450/2318-9312.v31.e1.a2019.pp46-53

Keywords:

omeprazole, primary health care, polypharmacy

Abstract

The first proton pump inhibitor (PPI) marketed worldwide was omeprazole. It is widely prescribed in Brazilian Primary Health Care nowadays. Studies indicate that long-term use may be related to significant adverse effects on the quality of life of the patient. The aim was to evaluate the prevalence and clinical profile of elderly patients using omeprazole in a Family Health Unit (FHU). A descriptive cross-sectional study was performed where was evaluated patients containing prescription for omeprazole from doctors of the FHU. One hundred elderly patients were included in the study. Thirty-five patients were omeprazole users, 10 of whom were male and 25, female. A dose of 20 mg daily was found in 68.6% of the users, 91.4% had a prescription for more than twelve months, and 51.4% had no described the reason of the use of omeprazole, 17.1% had stomach pain as a justification for their use. Omeprazole may be prescribed without a clear indication of its use and for prolonged periods contributing to the inappropriate use of this drug.

Author Biographies

Jean Mozart de Lima, Universidade de São Paulo. Faculdade de Medicina de Ribeirão Preto. Programa de Residência Multiprofissional em atenção integral a saúde. Av. Bandeirantes, 3900 - Monte Alegre - CEP: 14049-900 Ribeirão Preto/SP.

Trabalho de conclusão do Programa de Residência Multiprofissional em atenção integral a saúde da Faculdade de medicina de Ribeirão Preto-SP-USP.

Area: Atenção Primária

Amaury Lelis Dal Fabbro, Universidade de São Paulo. Faculdade de Medicina de Ribeirão Preto. Departamento de Medicina Social. Av. Bandeirantes, 3900 - Monte Alegre - CEP: 14049-900 Ribeirão Preto/SP.

Professor Associado do Departamento de Medicina Social da Faculdade de Medicina de Ribeirão Preto da Universidade de São Paulo. Médico - FMRP-USP.

Áreas de interesse: Epidemiologia, Atenção Primária à Saúde, Saúde Pública, Medicina Comunitária. (Fonte: Currículo Lattes)

André Rodrigues Funayama, Fundação de Apoio Ao Ensino, Pesquisa e Assistência do HCFMRP-USP. Av. Bandeirantes, 3900 - Vila Monte Alegre, Ribeirão Preto - SP, 14048-900

Médico de Família e Comunidade. Área: Saúde da Família

Downloads

Published

2019-04-01

How to Cite

de Lima, J. M., Dal Fabbro, A. L., & Funayama, A. R. (2019). USE OF OMEPRAZOL: DESCRIPTIVE STUDY OF ELDERLY PATIENTS FROM A FAMILY HEALTH UNIT (FHU) OF RIBEIRÃO PRETO, SP, BRASIL. Infarma - Pharmaceutical Sciences, 31(1), 46–53. https://doi.org/10.14450/2318-9312.v31.e1.a2019.pp46-53

Issue

Vol. 31 No. 1 (2019)

Section

Original article

License

Authors who publish in this journal agree to the following terms:

 

  1. Authors retain the copyright and grant the journal the right of first publication, with the work simultaneously licensed under the Licença Creative Commons Attribution which allows the sharing of work with acknowledgment of authorship and initial publication in this journal.
  2. Authors are authorized to take additional contracts separately, for non-exclusive distribution of the version of the work published in this journal (e.g. publish in institutional repository or as a book chapter), with acknowledgment of authorship and initial publication in this journal.
  3. Authors are allowed and encouraged to publish and distribute their work online (e.g. in institutional repositories or on their personal page) at any point before or during the editorial process, as this can generate productive changes as well as increase the impact and Citation of published work (See O Efeito do Acesso Livre ).